Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Aug
30
2022
Charging for Investigational Drugs Under an IND Questions and Answers, Draft Guidance for Industry, August 2022 Sheppard, Mullin, Richter & Hampton LLP
Aug
30
2022
Canada Establishes New Maximum Levels for Arsenic in Certain Foods Keller and Heckman LLP
Aug
30
2022
Nevada Supreme Court Rules That Recreational Use of Marijuana Is Not Protected Off-Duty Conduct ArentFox Schiff LLP
Aug
30
2022
Perspectives on the Evolving Regulatory Landscape for US Food and Beverage Squire Patton Boggs (US) LLP
Aug
30
2022
Delta-8: What Is and What Should Never Be Bradley Arant Boult Cummings LLP
Aug
29
2022
US Executive Branch Update – August 29, 2022 Squire Patton Boggs (US) LLP
Aug
29
2022
Biometric Privacy Statutes and Insurance Coverage: Recent Developments in Illinois and the National Landscape K&L Gates
Aug
29
2022
Get Up, Stand Up – Dispensary Challenges City’s Local Permitting Decision in Court Bradley Arant Boult Cummings LLP
Aug
29
2022
EPA Releases Long-Awaited Proposed Rule Designating Certain PFAS as CERCLA Hazardous Substances ArentFox Schiff LLP
Aug
29
2022
Summer 2022: Key Trends in Pharmacy Enforcement Actions Mintz
Aug
28
2022
Plans to Increase Data Requirements for REACH Registration, Including Significant Increase at the 1-10 Ton/Year Level, and Adoption of New Approach Methodologies Keller and Heckman LLP
Aug
26
2022
EPA Will Propose Revisions to RMP Rule to Enhance Chemical Safety Bergeson & Campbell, P.C.
Aug
26
2022
Departments Issue Final Rule Implementing Certain No Surprises Act Provisions McDermott Will & Emery
Aug
26
2022
No (More) Bites at the mRNA Apple: Pfizer and BioNTech Seek Declaratory Judgment of Noninfringement Relating to Their COVID-19 Vaccine in New Suit K&L Gates
Aug
26
2022
Will the Supreme Court’s Latest Decision on Mens Rea Leave Medical Professional Prosecutions Ruan-ing on Empty? Epstein Becker & Green, P.C.
Aug
26
2022
Nevada Court Rejects Claim That Off-Duty Marijuana Use Is “Lawful” Because It Still Is Illegal Under Federal Law Jackson Lewis P.C.
Aug
26
2022
USDA Accepting Applications for $100 Million in Biofuel Infrastructure Grants Bergeson & Campbell, P.C.
Aug
25
2022
FDA Publishes 2022 Retail Food Program Standards Keller and Heckman LLP
Aug
25
2022
Healthcare Reforms Under the IRA: Expanding Access to Care Sheppard, Mullin, Richter & Hampton LLP
Aug
25
2022
Can’t Dismiss Lanham Act Claim Based on FDCA Preemption McDermott Will & Emery
Aug
24
2022
Federal Court Rejects Terms in Franchise Agreement Retaining Data Access Rights As Sufficient to Plead Section 15(b) BIPA Claim Squire Patton Boggs (US) LLP
Aug
24
2022
Nevada High Court Rules Recreational Marijuana Is Not ‘Lawful Off-Duty Conduct’ Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Aug
24
2022
The Latest in Multi-Jurisdictional Marijuana Compliance Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Aug
24
2022
Walmart’s Fudge Mint Class Action Permanently Dismissed Keller and Heckman LLP
Aug
23
2022
Proposed Revisions to Medicare Shared Savings Program: CMS Encourages Participation
Aug
23
2022
EPA New Chemicals Program Will Discontinue Use of Exposure Modeling Thresholds When Assessing Health and Environmental Risks Bergeson & Campbell, P.C.
Aug
23
2022
Researchers Examine How Potassium in Biomass Feedstocks Poisons a Catalyst Bergeson & Campbell, P.C.
Aug
23
2022
The Dormant Commerce Clause and Discrimination in Illegal Interstate Markets Pierce Atwood LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins